Tus kws kho mob
P55-17 Prior Authorization Requirement for Orthognathic Surgery
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3181 - 3190 ntawm 3669
Tus kws kho mob
P14-18 Delay of Second Phase Transition with Magellan
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P30-17 New Drug-Related Prior Authorization (PA) Criteria: Topical Retinoids
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 05, 2017
Tus kws kho mob
P41-18 Update: Change to TPA Business
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 04, 2018
Tus kws kho mob
P69-17 New Reimbursement Policy for Inpatient Facility: Inpatient Short Stay
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P74-17 Payment Methodology Change for Interim Billing
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 29, 2017
Tus kws kho mob
P51-18 Lab Management Program CPT Code Update for Fully Insured Commercial Members - eviCore Healthcare Specialty Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P52-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Parathyroid Hormone Analog for Osteoporosis
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 03, 2017
Tus kws kho mob
P9-17 A New Drug, Ingrezza (valbenazine) Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 21, 2017
Tus kws kho mob
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 14, 2017